Transcranial Magnetic Stimulation

Research output: Chapter in Book/Conference paperChapter

Abstract

Transcranial magnetic stimulation (TMS) is gaining
increasing prominence as a non-invasive neuromodulation
technique for the treatment of
neurological and psychiatric conditions. Repetitive
transcranial magnetic stimulation (rTMS)
has therapeutic potential for a range of psychiatric
disorders (e.g. depression, schizophrenia) as
well as neurological disorders such as Parkinson’s
disease. The approach has advantages over pharmacological
or electroconvulsive therapy due to its painlessness and limited side effects. The magnitude, duration and direction (increase or decrease) of TMS-induced changes in brain excitability vary depending on the strength and timing of stimulation and the interaction of stimulation coil geometry with brain structures. The outcomes of TMS stimulation can also depend on the characteristics (e.g. age, exercise status) of the individual being treated. Despite increasing clinical use of rTMS, the cellular and network mechanisms underlying the clinical application of rTMS remain elusive and will need to be better understood to enable optimisation of clinical outcomes.
Original languageEnglish
Title of host publicationeLS
Place of PublicationChichester
PublisherJohn Wiley & Sons
ISBN (Electronic)9780470015902
DOIs
Publication statusPublished - 17 Apr 2019

Fingerprint

Transcranial Magnetic Stimulation
Electroconvulsive Therapy
Brain
Nervous System Diseases
Psychiatry
Schizophrenia
Depression
Therapeutics

Cite this

Seewoo, Bhedita Jaya ; Etherington, Sarah ; Rodger, Jennifer. / Transcranial Magnetic Stimulation. eLS. Chichester : John Wiley & Sons, 2019.
@inbook{04608d76258e4ce4bc6ebdf04d6385e9,
title = "Transcranial Magnetic Stimulation",
abstract = "Transcranial magnetic stimulation (TMS) is gainingincreasing prominence as a non-invasive neuromodulationtechnique for the treatment ofneurological and psychiatric conditions. Repetitivetranscranial magnetic stimulation (rTMS)has therapeutic potential for a range of psychiatricdisorders (e.g. depression, schizophrenia) aswell as neurological disorders such as Parkinson’sdisease. The approach has advantages over pharmacologicalor electroconvulsive therapy due to its painlessness and limited side effects. The magnitude, duration and direction (increase or decrease) of TMS-induced changes in brain excitability vary depending on the strength and timing of stimulation and the interaction of stimulation coil geometry with brain structures. The outcomes of TMS stimulation can also depend on the characteristics (e.g. age, exercise status) of the individual being treated. Despite increasing clinical use of rTMS, the cellular and network mechanisms underlying the clinical application of rTMS remain elusive and will need to be better understood to enable optimisation of clinical outcomes.",
author = "Seewoo, {Bhedita Jaya} and Sarah Etherington and Jennifer Rodger",
year = "2019",
month = "4",
day = "17",
doi = "10.1002/9780470015902.a0028620",
language = "English",
booktitle = "eLS",
publisher = "John Wiley & Sons",
address = "United States",

}

Transcranial Magnetic Stimulation. / Seewoo, Bhedita Jaya; Etherington, Sarah; Rodger, Jennifer.

eLS. Chichester : John Wiley & Sons, 2019.

Research output: Chapter in Book/Conference paperChapter

TY - CHAP

T1 - Transcranial Magnetic Stimulation

AU - Seewoo, Bhedita Jaya

AU - Etherington, Sarah

AU - Rodger, Jennifer

PY - 2019/4/17

Y1 - 2019/4/17

N2 - Transcranial magnetic stimulation (TMS) is gainingincreasing prominence as a non-invasive neuromodulationtechnique for the treatment ofneurological and psychiatric conditions. Repetitivetranscranial magnetic stimulation (rTMS)has therapeutic potential for a range of psychiatricdisorders (e.g. depression, schizophrenia) aswell as neurological disorders such as Parkinson’sdisease. The approach has advantages over pharmacologicalor electroconvulsive therapy due to its painlessness and limited side effects. The magnitude, duration and direction (increase or decrease) of TMS-induced changes in brain excitability vary depending on the strength and timing of stimulation and the interaction of stimulation coil geometry with brain structures. The outcomes of TMS stimulation can also depend on the characteristics (e.g. age, exercise status) of the individual being treated. Despite increasing clinical use of rTMS, the cellular and network mechanisms underlying the clinical application of rTMS remain elusive and will need to be better understood to enable optimisation of clinical outcomes.

AB - Transcranial magnetic stimulation (TMS) is gainingincreasing prominence as a non-invasive neuromodulationtechnique for the treatment ofneurological and psychiatric conditions. Repetitivetranscranial magnetic stimulation (rTMS)has therapeutic potential for a range of psychiatricdisorders (e.g. depression, schizophrenia) aswell as neurological disorders such as Parkinson’sdisease. The approach has advantages over pharmacologicalor electroconvulsive therapy due to its painlessness and limited side effects. The magnitude, duration and direction (increase or decrease) of TMS-induced changes in brain excitability vary depending on the strength and timing of stimulation and the interaction of stimulation coil geometry with brain structures. The outcomes of TMS stimulation can also depend on the characteristics (e.g. age, exercise status) of the individual being treated. Despite increasing clinical use of rTMS, the cellular and network mechanisms underlying the clinical application of rTMS remain elusive and will need to be better understood to enable optimisation of clinical outcomes.

U2 - 10.1002/9780470015902.a0028620

DO - 10.1002/9780470015902.a0028620

M3 - Chapter

BT - eLS

PB - John Wiley & Sons

CY - Chichester

ER -